This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Update

James T. Caroscio, MD; Shaul Kochwa, PhD; Henry Sacks, PhD, MD; Jeffrey A. Cohen, MD; Melvin D. Yahr, MD

Arch Neurol. 1983;40(7):409-413.

Abstract
• To compare four ways of measuring CSF IgG levels in diagnosing multiple sclerosis (MS), we analyzed CSF samples of 106 patients with clinically definite, probable, or possible MS and 127 patients with other diseases. The IgG synthetic rate and IgG index were the most sensitive tests at 0.88 and 0.94, respectively; IgG alone and IgG-albumin ratio, at 0.53 and 0.59, were less valuable. The IgG synthetic rate (0.87) was more specific than the IgG index (0.73), making it the quantitative measure that best correlated with a clinical diagnosis of definite MS. However, combining these four methods showed an even higher correlation. Quantitative CSF IgG elevations occurred much less frequently in patients with clinically definite MS receiving immunosuppressives and in those with clinically probable and possible MS. We did not perform qualitative CSF IgG measurements, but our methods' sensitivity and specificity were comparable with those attributed to oligoclonal IgG bands by others. We also found numerous other diseases where elevations of CSF IgG occurred by all four methods.

Author Affiliations
From the Departments of Neurology (Drs Caroscio, Cohen, and Yahr) Pathology and Medicine (Dr Kochwa) and Biomathematical Sciences (Dr Sacks), Mount Sinai School of Medicine, New York.

Footnotes
Accepted for publication Jan 6, 1983.

Reprint requests to Department of Neurology, The Mount Sinai School of Medicine, 1 Gustave L. Levy Pl, New York, NY 10029 (Dr Caroscio).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis
Lindsey et al.
Neurology 2008;71:35-37.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Cohen et al.
Arch Neurol 2000;57:553-557.
ABSTRACT | FULL TEXT  

Quantitative Cerebrospinal Fluid IgG Measurements as a Marker of Disease Activity in Multiple Sclerosis
Caroscio et al.
Arch Neurol 1986;43:1129-1131.
ABSTRACT  

The Spinal Tap: A New Look at an Old Test
MARTON and GEAN
ANN INTERN MED 1986;104:840-848.
ABSTRACT  

The Diagnostic Spinal Tap
ANN INTERN MED 1986;104:880-885.
ABSTRACT  

Quantitative CSF IgG Measurements
Hershey et al.
Arch Neurol 1984;41:473-473.
ABSTRACT